Leadership UncertaintyThe unforeseen retirement of long-time CEO Glen French and the resignation of CFO Derrick Sung overshadowed the refocused strategy that reaccelerated 2023 growth to 28% from 11% in 2022.
Management ChangesThe unforeseen retirement of long-time CEO Glen French and the resignation of CFO Derrick Sung overshadowed the refocused strategy that reaccelerated 2023 growth.
Stock PerformanceThere is inherent uncertainty that comes with any management change, but the stock's 50% decline since announcing the CEO change does not accurately reflect Pulmonx's underlying fundamentals.